Genital condyloma acuminata in elderly woman treated with topical imiquimod 5% cream: A case report
DOI:
https://doi.org/10.66344/jpad.v32i1.1830Abstract
Introduction: Condyloma acuminata (CA) is the most common sexually transmitted infection caused by human papillomavirus (HPV). Transmission mainly through sexual intercourse and affects the population between the ages of 25 and 44, although it can occur in older people. Treatments that can be administered are podophyllin, trichloroacetic acid (TCA), imiquimod, 5-fluorouracil, and surgery. Self-administered topical imiquimod has a low recurrence rate. Case report: A 64-year-old woman presents with genital warts since 5 years ago. It was painless and did not bleed easily. Venereology status revealed multiple verrucous papules. Discussion: Genital warts didn’t achieve complete clearance, getting bigger and growing in numbers. Trichloroacetic acid and podophyllin had been administered to the patient once a week for the past 2 years, the warts have decreased in size and then grow again. The patient was advised to undergo surgery, but the patient refused. Then, the patient was given imiquimod 5% cream, 3 times a week for 24 weeks. There was no recurrence after 1 year discontinuation of treatment. Conclusion: A case of genital condyloma acuminata has been reported in elderly woman who was treated with imiquimod 5% cream for 24 weeks and showed a significant improvement.
References
1. Winer RL, Koutsky LA. Genital Human Papillomavirus Infection. In: Holmes KK, Sparling PF, Cox N, Stamm W, editor. Sexually transmitted disease. 4th edition. New York: McGraw Hill; 2008. p.489-508.
2. World Health Organization. Sexually Transmitted Infections (STIs). Fact Sheets. 2019.
3. Niode N J. Management of Human Papillomavirus Infection and Immunomodulator Roles. Proceeding Book of the 23rd Regional Conference of Dermatology, 2018 August 8-11; Surabaya, Indonesia.
4. Indriatmi W, Zubier F. Kondiloma Akuminata. In: Daili SF, Nilasari H, Makes WI, Zubier F, Romawi R, Pudjiati S, editor. Infeksi Menular Seksual. 5th edition. Badan Penerbit Fakultas Kedokteran Universitas Indonesia. 2017. p.176-87.
5. Kimbauer R, Lenz P. Human Papillomaviruses. In: Bolognia JL, Jorizzo JL, Schaffer J V, editor. Dermatology. 3th edition. Spain : Mosby. 2012. p.1303-19.
6. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia. Panduan Pelayanan Medis Dokter Spesialis Kulit dan Kelamin. Perdoski. 2017. p.368-71.
7. Hum M, Chow E, Schuurmans N, Dytoc M. Case of Giant Vulvar Condyloma Acuminata Successfully Treated With Imiquimod 3.75% Cream: A Case Report. SAGE Open Med Case Rep. 2018;6:2050313X18802143.
8. Sterling J C. Human Papillomavirus Infections. In: Kang S, Amagai M, Bruckner A L, Enk A, Margolis D, Mc Michael A, et al. Fitzpatrick’s Dermatology in General Medicine. 9th edition. New York : McGraw Hill Companies. 2019. p.3102-6,3594-5.
9. James WD, Berger TG, Elston DM. Papovavirus Group. Andrew’s Disease of the Skin Clinical Dermatology. 12th edition. Philadelphia: Saunders Elsevier. 2016. p.399-407.
10. Deshmukh S, Singh S, Jawade S, Madke B, Singh AL. Treatment of Genital Warts With a Combination of Cryotherapy and 5% Imiquimod. J Clin Diagnost Res. 2020;14(2):WD01-WD03.
11. Reddy GS, Lal BM, Prasad J, Krishna AV, Rani KR, Gayatri N. Comparative Study of Efficacy of Podophyllin vs 5% Imiquimod in the Treatment of Genital Warts. Int J Contemp Med Res. 2018;5(10):18-11.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Hyacintha Puspitasari Budi, Dwi Martina Trisnowati, Nurdjannah Jane Niode, Enricco Hendra Mamuaja
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
